RxDoctor Payments Data

Robert Marsh

Family Medicine · Minnetonka, MNNPI 1659428019

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $298,200 of the $300,180 with a category attached, or 99.3%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 88.4% of it on its own, with 2 other manufacturers making up the rest. Among family medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$300,180in general payments, 2019–2025

Across 183 payments — averaging $1640.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$265K
  • Shire North American Group Inc$35K
  • Zimmer Biomet$15

What the payments were for

  • Consulting fees$298,20099%
  • Travel & lodging$1,9661%
  • Food & beverage$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$300,180 in reported general payments places this provider in the 95th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota →

Other family medicine in Minnetonka

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →